相关实验视频

Updated: Jun 26, 2025

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection

Published on: June 23, 2023

在质瘤中KIFC1的高表达与预后不佳相关

Pengfei Xue¹, Juan Zheng², Rongrong Li²

¹Department of Neurosurgery, Liaocheng People's Hospital, Liaocheng, China.

Journal of Korean Neurosurgical Society

|May 9, 2024

概括

素家族成员C1 (KIFC1) 在质瘤中被上调,促进瘤的进展. 较低的KIFC1水平与更好的患者预后相关,这表明KIFC1是质瘤的潜在治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
细胞生物学细胞生物学

背景情况:

基因素家族成员C1 (KIFC1) 涉及中枢细胞组聚和癌症进展.
它在常见的大脑瘤质瘤中的作用尚不清楚.

研究的目的:

研究KIFC1在质瘤进展中的作用.
确定KIFC1作为预后生物标志物和治疗点的潜力.

主要方法:

对KIFC1表达和临床结果的生物信息学分析.
免疫组织化学测试以评估质瘤和正常组织中的KIFC1水平.
在体外研究涉及KIFC1在质瘤细胞系 (U251,U87MG) 中的淘汰,以分析扩散,入侵,迁移和自流.

主要成果:

在质瘤组织中,KIFC1的表达显著升高,与瘤等级有积极的相关性.
高KIFC1表达与较差的患者预后有关.
通过KIFC1的淘汰,抑制了结质瘤细胞的增殖,迁移和入侵,同时增加了自流和减少了MMP2的表达.

结论:

上调的KIFC1促进了质瘤的进展.
KIFC1代表了潜在的预后生物标志物和治疗质瘤治疗的治疗点.

关键词:

自自是一种自的过程.质瘤是一种质瘤.一个KIFC1一个KIFC1 矩阵金属蛋白酶-2的作用.

更多相关视频

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

相关概念视频

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...